Lume lung2 Clinical Trial Infographic (Boehringer Ingelheim)

Boehringer Ingelheim's creative use of infographics for patient recruitment in clinical trials

Read more about musician Joe Nichols joining with Boehringer Ingelheim in its campaign to raise awareness about IPF.

Country Music Star Joe Nichols Shares His Dad’s IPF Story in ‘Breathless,’ a Public Awareness Campaign

Read about how Country Music Artist Joe Nichols and Boehringer Ingelheim Pharmaceuticals Launch Breathless™, a Campaign to Raise Awareness for IPF

@Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. The objectives and beliefs of Boehringer Ingelheim can be summed up in a single phrase: Value through Innovation. http://www.boehringer-ingelheim.com/

KEYNOTE: Wolfram Carlus, Formerly of Boeringer Ingelheim, speaks on the Future of Biotech

Boehringer Ingelheim’s Stiolto Respimat COPD treatment approved by FDA

Popular Acid Reflux Drugs Are Linked To Kidney Disease Risk People who take certain popular medicines for heartburn, indigestion and acid reflux may want to proceed more cautiously, researchers reported Monday.

como afecta la diabetes a la retinopatia diabetica - boehringer ingelheim diabetes espa�a.fotos de ulceras de diabetes enfermeria pie diabetico 2016 tarragona fluconazol para diabeticos 4316398561

Alimentos Naturales Para La Diabetes

como afecta la diabetes a la retinopatia diabetica - boehringer ingelheim diabetes espa�a.fotos de ulceras de diabetes enfermeria pie diabetico 2016 tarragona fluconazol para diabeticos 4316398561

Boehringer Ingelheim Announces Spiolto Respimat Availability in Europe for COPD COPD News Today

Boehringer Ingelheim Announces Spiolto Respimat Availability in Europe for COPD

Read about Boehringer Ingelheim’s OFEV (nintedanib) IPF therapy that saw its efficacy and safety profile reinforced in new studies.

Boehringer Ingelheim’s OFEV (Nintedanib) IPF Therapy Reinforces Efficacy and Safety Profile in New Studies

Read about Boehringer Ingelheim’s OFEV (nintedanib) IPF therapy that saw its efficacy and safety profile reinforced in new studies.

Boehringer Ingelheim on walking the talk in patient-centricity

Boehringer Ingelheim on walking the talk in patient-centricity

In 1941, Aludrin® - a respiratory product and new approach in treating asthma -  was launched.  "Copyright Boehringer Ingelheim"

In Aludrin® - a respiratory product and new approach in treating asthma - was launched.

Boehringer will seinen größten Standort in Ingelheim beibehalten - die Produktion wandert teilweise dennoch ins Ausland. (Foto: Boehringer Ingelheim)

Boehringer will seinen größten Standort in Ingelheim beibehalten - die Produktion wandert teilweise dennoch ins Ausland. (Foto: Boehringer Ingelheim)

Video version of animated oncology infographic from Boehringer Ingelheim portraying the frequency of breast cancer, the different stages of tumour growth as well as common symptoms of breast cancer in an understandable way.    For more Oncology informational videos please click here: http://www.youtube.com/Oncology     ONLY for Media and HCPs: Visit...

Video version of animated oncology infographic from Boehringer Ingelheim portraying the frequency of breast cancer, the different stages of tumour growth as .

Boehringer Ingelheim Announces Several Idiopathic Pulmonary Fibrosis Presentations at Upcoming International Scientific Meeting Pulmonary Fibrosis News

Boehringer Ingelheim Announces Several Idiopathic Pulmonary Fibrosis Presentations at Upcoming International Scientific Meeting

The secondary endpoints for efficacy, safety and immunogenicity of BI 695501 vs. Humira, were also met.

Boehringer Ingelheim launches gamified support program - Medical Marketing and Media

BI launched a new gamified patient support program aimed at improving adherence to its COPD medication.

<span class="entry-title">IBD Research to Advance with Boehringer Ingelheim New Partnerships</span><span class="entry-subtitle">Company joins with 4 scientific institutions to develop, support new innovative therapies</span>

IBD Research to Advance with Boehringer Ingelheim New Partnerships

Read about the expected advances in IBD research with Boehringer Ingelheim new announced partnerships with four leading scientific institutions.

Pinterest
Search